HOME >> BIOLOGY >> NEWS
Huntington's disease study shows animal models on target

This release is available in French.

An international team of researchers has published a benchmark study showing that gene expression in several animal models of Huntingtons Disease (HD) closely resembles that of human HD patients.

The results, published August 1, 2007, in the journal Human Molecular Genetics, validate the applicability of using animal models to study human disease and will have important consequences for the pertinence of these models in preclinical drug testing.

Huntington's disease is an incurable and fatal hereditary neurodegenerative disorder caused by a mutation in the gene that encodes the huntingtin protein. Neurons in certain regions of the brain succumb to the effects of the altered protein, leading to severe motor, psychiatric, and cognitive decline. Several recent studies have shown that the mutant huntingtin protein modifies the transcriptional activity of genes in affected neurons. This disease mechanism is a promising new avenue for research into the causes of neuronal death and a novel potential approach for treatment.

Led by EPFL professor Ruth Luthi-Carter, and involving collaborators from six countries, the current study found a marked resemblance between the molecular etiology of neurons in animal models and neurons in patients with HD. This implies that animal models are relevant for studying human HD and testing potential treatments.

To come to this conclusion, the scientists measured the gene expression profile of seven different transgenic mouse models of HD, representing different conditions and disease stages. These profiles clarified the role of different forms and dosages of the protein hungtintin in the transcriptional activity of neurons. They then designed and implemented novel computational methods for quantifying similarities between RNA profiles that would allow for comparisons
'"/>

Contact: Alexandre Kuhn
alexandre.kuhn@epfl.ch
41-216-931-731
Ecole Polytechnique Fdrale de Lausanne
31-Jul-2007


Page: 1 2

Related biology news :

1. Drug protects brain cells in Huntingtons disease model, researchers find
2. Better sleep may put Huntingtons disease sufferers back on track
3. Subtle signs can help predict Huntingtons disease early
4. Landmark study identifies large number of new proteins implicated in Huntingtons disease
5. Study links faulty DNA repair to Huntingtons disease onset
6. Proteasome activator enhances survival of Huntingtons disease neuronal model cells
7. Test reveals effectiveness of potential Huntingtons disease drugs
8. Metabolic disorder underlies Huntingtons disease
9. Unique Huntingtons study moves forward
10. Gene therapy injected into the brains of mice with Huntingtons disease
11. Research suggests cause of neurodegeneration in Huntingtons disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/29/2018)... (PRWEB) , ... July 29, 2018 , ... Dr. William ... biofield energy treated nutraceutical to improve overall immunity and to combat inflammation and autoimmune ... well as inflammation. The following data was reported:, Up ...
(Date:7/28/2018)... (PRWEB) , ... July 28, 2018 , ... ... at The Hong Kong Polytechnic University (PolyU), has been honoured with the International ... to the field of wind engineering and bridge engineering in research, education, and ...
(Date:7/26/2018)... ... July 25, 2018 , ... ... C-level biopharma executives on September 4, 2018 at The Hilton Boston Back Bay ... from real-life business development experiences and dissect the most relevant deals in biotech. ...
Breaking Biology News(10 mins):
(Date:7/31/2018)... ... July 31, 2018 , ... Leading regenerative veterinary medicine ... extracting and using adipose tissue-derived stem cells to treat or prevent inflammation at ... patent covers Canada specifically, VetStem has been issued similar patents that cover the ...
(Date:7/27/2018)... ... July 27, 2018 , ... ... Advocacy Group (BRAG®) and representatives of the Biotechnology Innovation Organization (BIO) met ... recently-issued white paper, “Proposal for a Toxic Substances Control Act (TSCA) Inventory ...
(Date:7/25/2018)... ... July 25, 2018 , ... Dimitrius ... proprietary nutraceutical to combat inflammation and autoimmune disorders. , The preclinical research ... The following data was reported:, Over 70% decrease ...
(Date:7/25/2018)... , ... July 25, 2018 , ... ... for managing clinical trial patient and supplies data through its flagship IXRS® ... on IRT: Best Practices.” , This podcast features both Almac thought leaders and ...
Breaking Biology Technology:
Cached News: